Terms: = Breast cancer AND DDX5, HLR1, 1655, ENSG00000108654, P17844, DKFZp686J01190, p68, G17P1, HUMP68 AND Treatment
23 results:
1. Wnt Signaling Pathway Collapse upon β-Catenin Destruction by a Novel Antimicrobial Peptide SKACP003: Unveiling the Molecular Mechanism and Genetic Activities Using breast cancer Cell Lines.
Selvarathinam K; Subramani P; Thekkumalai M; Vilwanathan R; Selvarajan R; Abia ALK
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770598
[TBL] [Abstract] [Full Text] [Related]
2. HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms.
Han BY; Liu Z; Hu X; Ling H
Cell Death Dis; 2022 Nov; 13(11):940. PubMed ID: 36347834
[TBL] [Abstract] [Full Text] [Related]
3. Identifying Patients Whose Symptoms Are Underrecognized During treatment With breast Radiotherapy.
Jagsi R; Griffith KA; Vicini F; Boike T; Dominello M; Gustafson G; Hayman JA; Moran JM; Radawski JD; Walker E; Pierce L;
JAMA Oncol; 2022 Jun; 8(6):887-894. PubMed ID: 35446337
[TBL] [Abstract] [Full Text] [Related]
4. Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer.
Tan Y; Sun R; Liu L; Yang D; Xiang Q; Li L; Tang J; Qiu Z; Peng W; Wang Y; Ye L; Ren G; Xiang T
Theranostics; 2021; 11(11):5214-5231. PubMed ID: 33859743
[No Abstract] [Full Text] [Related]
5. Transcriptomics and Prognosis Analysis to Identify Critical Biomarkers in Invasive breast Carcinoma.
Wu J; Liu XJ; Hu JN; Liao XH; Lin FF
Technol Cancer Res Treat; 2020; 19():1533033820957011. PubMed ID: 33176622
[TBL] [Abstract] [Full Text] [Related]
6. RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast cancer.
Tentler JJ; Lang J; Capasso A; Kim DJ; Benaim E; Lee YB; Eisen A; Bagby SM; Hartman SJ; Yacob BW; Gittleman B; Pitts TM; Pelanda R; Eckhardt SG; Diamond JR
BMC Cancer; 2020 Nov; 20(1):1063. PubMed ID: 33148223
[TBL] [Abstract] [Full Text] [Related]
7. First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative breast cancer.
Capasso A; Bagby SM; Dailey KL; Currimjee N; Yacob BW; Ionkina A; Frank JG; Kim DJ; George C; Lee YB; Benaim E; Gittleman B; Hartman SJ; Tan AC; Kim J; Pitts TM; Eckhardt SG; Tentler JJ; Diamond JR
Mol Cancer Ther; 2019 Nov; 18(11):1916-1925. PubMed ID: 31488700
[TBL] [Abstract] [Full Text] [Related]
8. Physical activity levels of women with breast cancer during and after treatment, a comparison with the Dutch female population.
Gal R; Monninkhof EM; Peeters PHM; van Gils CH; van den Bongard DHJG; Wendel-Vos GCW; Zuithoff NPA; Verkooijen HM; May AM
Acta Oncol; 2019 May; 58(5):673-681. PubMed ID: 30724657
[No Abstract] [Full Text] [Related]
9. The role of DEAD-box RNA helicase p68 (ddx5) in the development and treatment of breast cancer.
Hashemi V; Masjedi A; Hazhir-Karzar B; Tanomand A; Shotorbani SS; Hojjat-Farsangi M; Ghalamfarsa G; Azizi G; Anvari E; Baradaran B; Jadidi-Niaragh F
J Cell Physiol; 2019 May; 234(5):5478-5487. PubMed ID: 30417346
[TBL] [Abstract] [Full Text] [Related]
10. Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study.
Lee JM; Nair J; Zimmer A; Lipkowitz S; Annunziata CM; Merino MJ; Swisher EM; Harrell MI; Trepel JB; Lee MJ; Bagheri MH; Botesteanu DA; Steinberg SM; Minasian L; Ekwede I; Kohn EC
Lancet Oncol; 2018 Feb; 19(2):207-215. PubMed ID: 29361470
[TBL] [Abstract] [Full Text] [Related]
11. Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experience.
Okines A; Irfan T; Khabra K; Smith I; O'Brien M; Parton M; Noble J; Stanway S; Somaiah N; Ring A; Johnston S; Turner N
Breast J; 2018 May; 24(3):253-259. PubMed ID: 28833867
[TBL] [Abstract] [Full Text] [Related]
12. The cost of newly diagnosed breast cancer in Lithuania, 2011.
Ivanauskienė R; Domeikienė A; Kregždytė R; Milašauskienė Ž; Padaiga Ž
Medicina (Kaunas); 2015; 51(1):63-8. PubMed ID: 25744777
[TBL] [Abstract] [Full Text] [Related]
13. Utilisation of primary and secondary G-CSF prophylaxis enables maintenance of optimal dose delivery of standard adjuvant chemotherapy for early breast cancer: an analysis of 1655 patients.
Chan A; McGregor S; Liang W
Breast; 2014 Oct; 23(5):676-82. PubMed ID: 25108452
[TBL] [Abstract] [Full Text] [Related]
14. Radiation-induced carotid artery atherosclerosis.
Gujral DM; Chahal N; Senior R; Harrington KJ; Nutting CM
Radiother Oncol; 2014 Jan; 110(1):31-8. PubMed ID: 24044796
[TBL] [Abstract] [Full Text] [Related]
15. ddx5 regulates DNA replication and is required for cell proliferation in a subset of breast cancer cells.
Mazurek A; Luo W; Krasnitz A; Hicks J; Powers RS; Stillman B
Cancer Discov; 2012 Sep; 2(9):812-25. PubMed ID: 22750847
[TBL] [Abstract] [Full Text] [Related]
16. RNA helicase ddx5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells.
Wang D; Huang J; Hu Z
Mol Cell Proteomics; 2012 Feb; 11(2):M111.011932. PubMed ID: 22086602
[TBL] [Abstract] [Full Text] [Related]
17. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.
Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E
J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292
[TBL] [Abstract] [Full Text] [Related]
18. Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter.
Jin W; Chen Y; Di GH; Miron P; Hou YF; Gao H; Shao ZM
J Biol Chem; 2008 Oct; 283(44):29671-80. PubMed ID: 18765668
[TBL] [Abstract] [Full Text] [Related]
19. [Effect of trastuzumab on tumor cell lines shedding high or low level of HER-2 ECD].
Liu CY; Yang W; Li JF; Sun SL; Shou CC
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):101-5. PubMed ID: 17645842
[TBL] [Abstract] [Full Text] [Related]
20. Attitudes and practices about postmenopausal hormone therapy among female gynecologists in Brazil.
Filho AS; Soares Júnior JM; Arkader J; Maciel GA; Baracat EC
Maturitas; 2005 Jun; 51(2):146-53. PubMed ID: 15917155
[TBL] [Abstract] [Full Text] [Related]
[Next]
